Conducted a series of Lifetech seminars

(Head office: Shinjuku-ku, Tokyo; President and CCO: Jyo Inoue), a platform for "solving unsolved issues (deep issues) with the collective power of science and technology (deep tech)" operated by LIVERNESS Co.TECH PLANTERIn the 2024 season, we invite entries for solutions to various scientific and technological issues, and work with researchers, venture companies, small and medium-sized enterprises, and large corporations to solve deep issues through PoC, mass production design, project creation, and implementation as a business in society. In the 2024 season, a new area, "Lifetech Grand PrixNewly establish "Newly establish "Newly establish "Newly establish "Newly establish

The meaning of the word "life" is not "life science" but "living. We aim to solve issues related to individual lives and ways of living that people face from birth to death through a collection of science and technology. There are various challenges that people face in living, such as health maintenance, mental health, pregnancy/childbirth/childcare, nursing care, social participation of people with physical or mental disabilities, or changes and diversity in lifestyles. We integrate knowledge related to "living,"Live x Technology to Enrich Life, Life, and Lifestyle."The goal of the project is toLifetech Grand PrixIt is.

In the form of a series of seminars, we will introduce what kind of deep issues exist in this area and what kind of technologies have been created and are beginning to run as businesses. We will also discuss how we can advance the resolution of issues in this area.

Seminar Scheduled to be held Online Distribution

All navigators

LIVERNESS Corporation
Chief Culture Officer (CCO)
Inoue, Jyo

D., Pharmacist, founded LIVERNESS in 2002 with only undergraduate and graduate students of science and engineering while in graduate school. After completing the doctoral process, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, an assistant professor at the Graduate School of Medicine, Kyoto University, and a specially appointed associate professor at Keio University before assuming and concurrently serving as a professor of advanced pharmacy at the Faculty of Pharmaceutical Sciences, Kumamoto University and a visiting professor at the Faculty of Pharmaceutical Sciences, Keio University in 2018. He is a researcher and manager involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes while conducting research and development. He is also a visiting professor at the Faculty of Entrepreneurship, Musashino University, a member of the Industrial Structure Council of the Ministry of Economy, Trade and Industry, an expert reviewer of technology for the Ministry of Education, Culture, Sports, Science and Technology, and a member of the JST SCORE-University Promotion Committee, and has been involved in the launch of many venture companies and has served as an advisor.

Session 1: Thursday, February 22, 2024, 5:00 p.m. - 6:00 p.m.Click here to register

Humanome Research Institute, Inc.
Jun Zeze, President and Representative Director

Session 2: Tuesday, February 27, 2024, 5:00 p.m. - 6:00 p.m.Click here to register

Rhelixa Corporation
Ryu Nakaki, Representative Director

Japan Healthcare Corporation
Dr. Daichi Okabe, Representative Director

Third session Tuesday, March 12, 2024, 5:00 p.m. - 6:00 p.m.Click here to register

EVE Care Co.
President and CEO: Mr. Kazushi Isozeki

Session 4: Wednesday, March 27, 2024, 10:00 - 11:00 a.m.Click here to register

Metagen Inc.
Mr. Masatsugu Fukuda, President and Representative Director

Inquiries

Liberace Corporation Maeda, Nishiyama
[email protected]
tel: 03-5227-4198